Penn Med researchers found that memory T and B cells play a significant role in fighting COVID-19 even 6 months after vaccination.

About 1 American child in 6 experiences obesity, says a new report from the Robert Wood Johnson Foundation. Deepening poverty has a big impact.

The upcoming FDA announcement is likely to come along with authorization for boosters of the Moderna and J&J shots and follows the authorization of a third dose for Pfizer.

Those who qualify for vaccine booster shots can now book appointments through the state’s scheduling system.

New Castle County will spend millions of American Rescue Plan funds to create a more equitable playing field for residents living in underserved communities.

Powell was the first African American to serve as chairman of the Joint Chiefs of Staff and secretary of state.

Much of the world is open to Americans, particularly vaccinated travelers, but the rules vary. Here’s what you need to know before you go.

In a 19-0 vote, the panel recommended that the booster dose come at least two months after initial immunization with one shot of the J&J vaccine.

Putting off surgeries or routine treatments for serious illnesses has become common during the pandemic, a new NPR/Harvard poll finds.

Philadelphia’s health commissioner said the city risks another epidemic of preventable deaths if health care workers don’t get inoculated against the coronavirus.

The tool provides a regularly updated look at the local economy, with results that can be filtered by ZIP code, industries, and other factors.

Vehicle, rail and ferry travel between the U.S. and Canada and Mexico has been largely restricted to essential travel, such as trade, since the earliest days of the pandemic.

One reason America's employers are having trouble filling jobs was starkly illustrated in a report Tuesday: Americans are quitting in droves.

After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters.

The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.